She joined the University of Arizona in 2000, and since then has been conducting research in Drug Discovery to treat chronic neuropathic pain with a new pathological paradigm. Before joining the University of Arizona, she worked for Hyundai Pharmaceutical in Korea for 5 years. At that time, as a team leader of a Peptide Lab, she developed new amino acid derivatives and new synthetic methodologies for biologically active peptide ligands. Originally her major was synthetic organic